Navigation Links
Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call
Date:1/30/2008

SOUTH SAN FRANCISCO, Calif., Jan. 30 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc., (Nasdaq: MGRM) announced that it will hold a conference call on Thursday, February 7, 2008 at 4:30 p.m. (Eastern Time) to discuss fourth quarter 2007 financial results and to discuss the outlook for 2008. The call will be hosted by Mr. William D. Young, Chairman and CEO of Monogram.

To participate in the live teleconference, please call (877) 545-1409, or (719) 325-4855 for international callers, fifteen minutes before the conference begins. Live audio of the call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. Following the live broadcast, a replay of the call will also be available at (888) 203-1112 or (719) 457-0820 for international callers, through Thursday, February 21, 2008. The replay passcode is 3649403. Access to live and archived audio of the conference call will be available by following the appropriate links at http://www.monogrambio.com and clicking on the Investor Relations link.

The information provided on the teleconference is only accurate at the time of the conference call, and Monogram will take no responsibility for providing updated information except as required by law.

About Monogram Biosciences, Inc.

Monogram is advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also b
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference
2. Monogram Announces Third Quarter 2007 Financial Results
3. Monogram Biosciences Announces Third Quarter 2007 Financial Results Conference Call
4. Monogram Biosciences to Present at the JMP Securities Healthcare Conference
5. Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference
6. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
7. Sangamo BioSciences Announces Fourth Quarter and Year-End 2007 Conference Call and Webcast
8. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
9. Profectus BioSciences Inc. Names Shawn Patrick OBrien CEO
10. Study Shows Coronado Biosciences Bcl-2 Inhibitor, Apogossypol, is More Efficacious, Less Toxic than Gossypol in Animal Models
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... 6 Myriant Technologies LLC ("Myri...ufacturer of renewable bio-chemicals, Uhde Corpor...ider Uhde GmbH, one of the world,s leading enginee...liance for the engineering, procurement & cons... plants based on renewable feedstocks. The execut...
(Date:11/6/2009)...Nov. 6 ,, 3Q09 Cor...Qutenza(TM) E.U. Marketing Authorization to Astell...in commercial readiness activities Expanded manag...arketing; and Director, Commercial Operations App...d Audit Committee chairman , Upcoming 2009 ...
(Date:11/6/2009)...Newswire-FirstCall/ - Oncolytics Biotech Inc. (TSX... today announced updated results from a Phase II s...arcomas metastatic to the lung in a poster present...y Society Meeting held in Miami Beach, Florida, fr...ntitled "A Phase II Study of Intravenous REOLYSIN ...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personalize...o take place on February 22-24, 2010 in Philadelph...ce we will highlight key issues in forming partner...experiences. , Minneapoli...rrowhead’s 2010 Personalized Medicine Partn...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
...ies Require Most Dramatic Changes , , NEW YORK, M...gles to manage rising risk, more than 40 percent o... of at least US$15 billion say that their companie... whole organization to survive the next decade, ac...ed by Deloitte Touche Tohmatsu (DTT). , , Reflect...
...s., March 9 Merrimack Pharmaceuticals, Inc., a pr...discovery and development of novel treatments for ...t Ulrik B. Nielsen has been promoted to Senior Vic...d (Tad) J. Stewart to Senior Vice President of Bus... played critical roles in building Merrimack int...
...ch 9 PURE Bioscience (Nasdaq: PURE ), creators ...timicrobial, today announced that John J. Carbone,... Dr. Carbone fills the vacancy left by the resigna...ogo: http://www.newscom.com/cgi-bin/prnh/2006011...EO and Chairman of PURE Bioscience, commented, "We...
Other Biology Technology:Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry 2Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry 3Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry 4Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry 5Merrimack Pharmaceuticals Promotes Ulrik B. Nielsen, Ph.D. to Chief Scientific Officer and Edward J. Stewart to Senior Vice President of Business Development 2PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors 2PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors 3PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors 4
(Date:11/6/2009)...ADELPHIA (November 06, 2009) The Monell Center an...ts of the Beijing International Meeting on Taste a...ation with the CAS, the meeting will be the first ...d in China. , Alan Leshner, Chief Executive Offi...cience and Executive Publisher of Science magazine...
(Date:11/4/2009)...ADELPHIA Although scientists are reluctant to off...ethod, evidence continues to grow about its protec...lished in Cancer Prevention Research , a journal ...hich suggests some reduction in oral cancer. , ...edicine in the Department of Thoracic/Head and Nec...
(Date:11/4/2009)...ouver, BC - Lowly bacteria, it turns out, hold the...ing plants around the world clean up toxic waste o...pecifically RDX, were invented back in World War I...ades. These high-energy compounds are often used ... version of TNT. , But with increased knowledg...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Genomic research will enable greener cleanup of military explosive test sites 21 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 11 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 2African American Office of Gay Concerns 28AAOGC 29 To Launch Status Is Everything HIV Testing Campaign 60175 1African American Office of Gay Concerns 28AAOGC 29 To Launch Status Is Everything HIV Testing Campaign 60175 2Anthem Blue Cross and Blue Shield in Missouri Earns NCQA Accreditation Status of Excellent 60173 1Anthem Blue Cross and Blue Shield in Missouri Earns NCQA Accreditation Status of Excellent 60173 2
...RGHCarnegie Mellon Universitys Chris T. Hendrickso...and Heather MacLean of the University of Toronto c...iminating dangerous carbon dioxide emissions that ...rchers found that farming and power generation are...issions per dollar output, according to research b...
...ease is available in German . , , Halle/S. The ...ogen could be lowered in future. Soil scientists a...(UFZ) have developed a new mathematical model whic...crobiological water treatment. Using the stable na...l, which is the most accurate to date, can for the...
...an Experts in the field of life in extreme environ...arctic Survey offices in Cambridge (UK) to officia...n for Research Activities on life in Extreme Envir...rging area of research in which Europe has conside...ch infrastructure. The science of such environment...
Other Biology News:Carnegie Mellon researchers to curb CO2 emissions 2New formula for combating the greenhouse gas nitrous oxide 2New formula for combating the greenhouse gas nitrous oxide 3New formula for combating the greenhouse gas nitrous oxide 4
Xylanase Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)
Goat Anti-Human p27 KIP 1 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Defender against cell death 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Goat Anti-Wnt-1 (G-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: